RVLPQRVL PharmaceuticalsRVLPQ info
$0.00info0.00%24h
Global rank
Market cap$11.14K
Change 7d0.00%
YTD Performance-97.14%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Business data

    RVL Pharmaceuticals (RVLPQ) Stock Overview

    RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. It is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.

    RVLPQ Stock Information

    Symbol
    RVLPQ
    Address
    400 Crossing BoulevardBridgewater, NJ 08807United States
    Founded
    -
    Trading hours
    -
    Website
    https://www.rvlpharma.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    908 809 1300

    RVL Pharmaceuticals (RVLPQ) Price Chart

    -
    Value:-

    RVL Pharmaceuticals Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.000099999997
    N/A
    Market Cap
    $11.14K
    N/A
    Shares Outstanding
    111.41M
    N/A
    Employees
    125.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org